{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:22:44Z","timestamp":1790796164320,"version":"4.1.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":1515,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The outcomes of patients with hypertrophic cardiomyopathy with left ventricular systolic dysfunction (HCM-LVSD) undergoing left ventricular assist device (LVAD) implantation remain unclear. We retrospectively evaluated the clinical impact of LVAD implantation on clinical outcomes, including haemodynamics and brain natriuretic peptide (BNP) levels, in patients with HCM-LVSD, in comparison with those with dilated cardiomyopathy (DCM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In this retrospective, single-centre, observational study conducted in Japan, the medical records of patients who underwent LVAD implantation in the National Cerebral and Cardiovascular Center between 2011 and 2020 were reviewed. We enrolled 96 patients with DCM (average age: 43.5 years; 73 men) and 24 patients with HCM-LVSD (average age: 48.3 years; 16 men). The HCM-LVSD group had smaller left ventricles with thicker ventricular walls than the DCM group, which became more prominent after LVAD implantation. Preoperatively, BNP values were comparable between both groups; however, 3 months post-implantation, they were significantly higher in the HCM-LVSD group. Pulmonary artery pulsatility index, right ventricular stroke work index, and cardiac index were lower, and right atrial pressure was higher, in the HCM-LVSD group, suggesting subclinical impairment of right ventricular function. The HCM-LVSD group demonstrated equivalent outcomes, including overall survival, cerebrovascular accidents, right ventricular failure, LVAD-related infections, arrhythmia, and aortic insufficiency, post-implantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite a decreased right ventricular function with higher BNP values, patients with HCM-LVSD and DCM showed comparable outcomes post-LVAD implantation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13653","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T02:08:00Z","timestamp":1635386880000},"page":"5513-5522","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Implantation of Ventricular Assist Devices in Hypertrophic Cardiomyopathy with Left Ventricular Systolic Dysfunction"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2632-5199","authenticated-orcid":false,"given":"Nobuichiro","family":"Yagi","sequence":"first","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center , 6-1 Kishibe-Shinmachi, Suita-shi, Osaka, 564-8565 ,","place":["Japan"]},{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Seguchi","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center , 6-1 Kishibe-Shinmachi, Suita-shi, Osaka, 564-8565 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Mochizuki","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center , 6-1 Kishibe-Shinmachi, Suita-shi, Osaka, 564-8565 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center , 6-1 Kishibe-Shinmachi, Suita-shi, Osaka, 564-8565 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiko","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center , 6-1 Kishibe-Shinmachi, Suita-shi, Osaka, 564-8565 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center , 6-1 Kishibe-Shinmachi, Suita-shi, Osaka, 564-8565 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Yanase","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center , 6-1 Kishibe-Shinmachi, Suita-shi, Osaka, 564-8565 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Tadokoro","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, National Cerebral and Cardiovascular Center , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satsuki","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, National Cerebral and Cardiovascular Center , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, National Cerebral and Cardiovascular Center , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihide","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center , 6-1 Kishibe-Shinmachi, Suita-shi, Osaka, 564-8565 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"key":"2026012114194532300_ehf213653-bib-0001","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"2026012114194532300_ehf213653-bib-0002","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"2026012114194532300_ehf213653-bib-0003","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jama.281.7.650","article-title":"Clinical course of hypertrophic cardiomyopathy in a regional United States cohort","volume":"281","author":"Maron","year":"1999","journal-title":"JAMA"},{"key":"2026012114194532300_ehf213653-bib-0004","first-page":"1339","article-title":"Implications of left ventricular remodeling in hypertrophic cardiomyopathy","volume":"81","author":"Maron","year":"1998","journal-title":"Am J Cardiol"},{"key":"2026012114194532300_ehf213653-bib-0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.967026","article-title":"Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging","volume":"5","author":"Olivotto","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2026012114194532300_ehf213653-bib-0006","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/CIRCULATIONAHA.119.044366","article-title":"Hypertrophic cardiomyopathy with left ventricular systolic dysfunction: insights from the SHaRe Registry","volume":"141","author":"Marstrand","year":"2020","journal-title":"Circulation"},{"key":"2026012114194532300_ehf213653-bib-0007","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy","volume":"114","author":"Harris","year":"2006","journal-title":"Circulation"},{"key":"2026012114194532300_ehf213653-bib-0008","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1002\/clc.20533","article-title":"Clinical features of the dilated phase of hypertrophic cardiomyopathy in comparison with those of dilated cardiomyopathy","volume":"33","author":"Hamada","year":"2010","journal-title":"Clin Cardiol"},{"key":"2026012114194532300_ehf213653-bib-0009","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.mayocp.2016.01.002","article-title":"Natural history of nonobstructive hypertrophic cardiomyopathy","volume":"91","author":"Hebl","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"2026012114194532300_ehf213653-bib-0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/europace\/euw327","article-title":"Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy","volume":"20","author":"Killu","year":"2018","journal-title":"Europace"},{"key":"2026012114194532300_ehf213653-bib-0011","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0735-1097(03)00855-6","article-title":"Clinical course of hypertrophic cardiomyopathy with survival to advanced age","volume":"42","author":"Maron","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026012114194532300_ehf213653-bib-0012","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","article-title":"Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies","volume":"65","author":"Maron","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026012114194532300_ehf213653-bib-0013","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.transproceed.2013.12.052","article-title":"Long-term outcomes of orthotopic heart transplantation for hypertrophic cardiomyopathy","volume":"46","author":"Lee","year":"2014","journal-title":"Transplant Proc"},{"key":"2026012114194532300_ehf213653-bib-0014","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cardfail.2017.09.011","article-title":"Outcomes of restrictive and hypertrophic cardiomyopathies after LVAD: an INTERMACS analysis","volume":"23","author":"Patel","year":"2017","journal-title":"J Card Fail"},{"key":"2026012114194532300_ehf213653-bib-0015","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/hrt.74.5.508","article-title":"Left ventricular chamber dilatation in hypertrophic cardiomyopathy: related variables and prognosis in patients with medical and surgical therapy","volume":"74","author":"Jenni","year":"1995","journal-title":"Br Heart J"},{"key":"2026012114194532300_ehf213653-bib-0016","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jacc.2005.04.062","article-title":"Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients","volume":"46","author":"Biagini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026012114194532300_ehf213653-bib-0017","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.jacc.2020.04.045","article-title":"Outcomes in patients with hypertrophic cardiomyopathy and left ventricular systolic dysfunction","volume":"75","author":"Rowin","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026012114194532300_ehf213653-bib-0018","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MAT.0000000000001238","article-title":"Left ventricular assist device implantation in hypertrophic and restrictive cardiomyopathy: a systematic review","volume":"67","author":"Sreenivasan","year":"2021","journal-title":"ASAIO J"},{"key":"2026012114194532300_ehf213653-bib-0019","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0002-8703(85)90561-7","article-title":"Three autopsy cases of progression to left ventricular dilatation in patients with hypertrophic cardiomyopathy","volume":"109","author":"Yutani","year":"1985","journal-title":"Am Heart J"},{"key":"2026012114194532300_ehf213653-bib-0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ahj.2008.01.035","article-title":"Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy","volume":"156","author":"Rold\u00e1n","year":"2008","journal-title":"Am Heart J"},{"key":"2026012114194532300_ehf213653-bib-0021","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1253\/jcj.48.1210","article-title":"Progression from hypertrophic obstructive cardiomyopathy to typical dilated cardiomyopathy-like features in the end stage","volume":"48","author":"Fujiwara","year":"1984","journal-title":"Jpn Circ J"},{"key":"2026012114194532300_ehf213653-bib-0022","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0735-1097(94)00432-P","article-title":"Response to isoproterenol as a prognostic indicator of evolution from hypertrophic cardiomyopathy to a phase resembling dilated cardiomyopathy","volume":"25","author":"Kawano","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"2026012114194532300_ehf213653-bib-0023","first-page":"304","article-title":"Pathological analysis of hypertrophic cardiomyopathy simulating dilated cardiomyopathy","volume":"43","author":"Kawashima","year":"1993","journal-title":"Acta Pathol Jpn"},{"key":"2026012114194532300_ehf213653-bib-0024","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.mri.2013.10.011","article-title":"Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome","volume":"32","author":"Machii","year":"2014","journal-title":"Magn Reson Imaging"},{"key":"2026012114194532300_ehf213653-bib-0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCHEARTFAILURE.110.959288","article-title":"Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy","volume":"4","author":"Topilsky","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026012114194532300_ehf213653-bib-0026","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/MAT.0000000000000234","article-title":"Serum brain natriuretic peptide concentration 60 days after surgery as a predictor of long-term prognosis in patients implanted with a left ventricular assist device","volume":"61","author":"Sato","year":"2015","journal-title":"ASAIO J"},{"key":"2026012114194532300_ehf213653-bib-0027","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/aor.12486","article-title":"B-type natriuretic peptide levels predict ventricular arrhythmia post left ventricular assist device implantation","volume":"39","author":"Hellman","year":"2015","journal-title":"Artif Organs"},{"key":"2026012114194532300_ehf213653-bib-0028","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MAT.0000000000000797","article-title":"Postoperative B-type natriuretic peptide as predictor for postoperative outcomes in patients implanted with left ventricular assist devices","volume":"65","author":"Yost","year":"2019","journal-title":"ASAIO J"},{"key":"2026012114194532300_ehf213653-bib-0029","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.hrthm.2018.04.030","article-title":"B-type natriuretic peptide and risk of sudden death in patients with hypertrophic cardiomyopathy","volume":"15","author":"Minami","year":"2018","journal-title":"Heart Rhythm"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13653","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13653","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/6\/5513\/65568964\/eschf_8_6_5513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/6\/5513\/65568964\/eschf_8_6_5513.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:23:44Z","timestamp":1769023424000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/8\/6\/5513\/8343730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,10,27]]},"published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13653","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12]]},"published":{"date-parts":[[2021,10,27]]},"assertion":[{"value":"2021-06-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}